Efficacy and Toxicity of Bimodal Radiotherapy in Patients With WHO Grade 2 Meningiomas Following Subtotal Resection With Carbon Ion Boost
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neuro-Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: prospective phase 2 MARCIE trial
Neuro-oncology 2023 Dec 11;[EPub Ahead of Print], MY Deng, SLN Maas, F Hinz, CP Karger, P Sievers, T Eichkorn, E Meixner, P Hoegen-Sassmannshausen, J Hörner-Rieber, JW Lischalk, K Seidensaal, D Bernhardt, C Jungk, A Unterberg, A Wick, W Wick, A von Deimling, F Sahm, S Combs, K Herfarth, J Debus, L KönigFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.